
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
DHER34 | B3 | BRL | Delayed | |
DHR | NYSE | USD | Real-time | |
DHR | Mexico | MXN | Delayed | |
DHR | BIVA | MXN | Delayed | |
1DHR | Milan | EUR | Real-time | |
DHR | TradeGate | EUR | Delayed | |
DHR | Frankfurt | EUR | Delayed | |
DHR | Vienna | EUR | Real-time | |
DHR | Lima | USD | Delayed |
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.
Name | Age | Since | Title |
---|---|---|---|
John T. Schwieters | 85 | 2003 | Independent Director |
Jessica L. Mega | 49 | 2019 | Independent Director |
David R. Walt | 72 | 2021 | Member of Scientific Advisory Board |
Alan G. Spoon | 74 | 1999 | Independent Director |
Sangeeta N. Bhatia | 56 | 2022 | Member of Scientific Advisory Board |
Raymond C. Stevens | 61 | 2017 | Independent Director |
Angela M. Caliendo | - | 2021 | Member of Scientific Advisory Board |
Charles W. Lamanna | - | 2025 | Director |
A. Shane Sanders | 61 | 2021 | Independent Director |
Carl H. June | 70 | 2022 | Member of the Scientific Advisory Board |
James J. Collins | 58 | 2021 | Member of Scientific Advisory Board |
Feroz Dewan | 49 | 2022 | Independent Director |
Mitchell P. Rales | 68 | 1983 | Co-Founder & Director |
Rainer M. Blair | 61 | 2014 | President, CEO & Director |
Steven M. Rales | 74 | 1983 | Co-Founder & Chairman |
Elias Adam Zerhouni | 74 | 2009 | Independent Director |
Linda Hefner Filler | 65 | 2005 | Lead Independent Director |
David L. Rimm | - | 2021 | Member of Scientific Advisory Board |
Robert M. Hershberg | 63 | - | Member of Scientific Advisory Board |
Teri L. List-Stoll | 62 | 2011 | Independent Director |
Phillip A. Sharp | 80 | 2021 | Member of Scientific Advisory Board |
Thomas Christian Sudhof | 70 | 2021 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review